| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 71.68× | 71.68× | 60.38× | 53.47× | 41.60× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 9.24× | 14.66× | 20.41× | 9.27× | −43.03× | ||
| 2.40× | 2.40× | 2.55× | 2.45× | 2.71× | ||
| −1.20× | −1.20× | −0.65× | 20.84× | 89.33× | ||
| −0.49× | −0.49× | −0.17× | 0.59× | −4.76× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 41.60 | 53.47 | 60.38 | 71.68 | 71.68 | |
| Working Capital Turnover | -43.03 | 9.27 | 20.41 | 14.66 | 9.24 | |
| Asset Turnover | 2.71 | 2.45 | 2.55 | 2.40 | 2.40 | |
| Cash Conversion (CFO/Net Income) | 89.33 | 20.84 | -0.65 | -1.20 | -1.20 | |
| CFO/EBITDA | -4.76 | 0.59 | -0.17 | -0.49 | -0.49 |